| ENTERA BIO IS-,0000769 |
| Israel |
| Gesundheit |
| IL0011429839 / A2JQXP |
| 5DT (Frankfurt) / ENTX (NASDAQ) |
| FRA:5DT, ETR:5DT, 5DT:GR, NASDAQ:ENTX |
| - |
| https://www.enterabio.com.. |
|
Entera Bio Ltd. is a clinical-stage biopharmaceutical company focusing on oral delivery solutions for large molecules, which traditionally require injection. The company's primary endeavor is to develop orally administered therapeutics aimed at unmet..
>Volltext.. |
| 51.61 Mio. EUR |
| 41.64 Mio. EUR |
| - |
| -10.89 Mio. EUR |
| -10.8 Mio. EUR |
| -0.23 EUR |
| 0.39 Mio. EUR |
| 10.41 Mio. EUR |
| -8.29 Mio. EUR |
| 7.57 |
| -100% |
| -14.85% |
| - |
| - |
| - |
| - |
| ENTERA BIO, ENTERABIO |
| 19.06.26 |
|